273 related articles for article (PubMed ID: 15151516)
1. Effects of single or combined histamine H1-receptor and leukotriene CysLT1-receptor antagonism on nasal adenosine monophosphate challenge in persistent allergic rhinitis.
Lee DK; Jackson CM; Soutar PC; Fardon TC; Lipworth BJ
Br J Clin Pharmacol; 2004 Jun; 57(6):714-9. PubMed ID: 15151516
[TBL] [Abstract][Full Text] [Related]
2. A placebo-controlled evaluation of butterbur and fexofenadine on objective and subjective outcomes in perennial allergic rhinitis.
Lee DK; Gray RD; Robb FM; Fujihara S; Lipworth BJ
Clin Exp Allergy; 2004 Apr; 34(4):646-9. PubMed ID: 15080820
[TBL] [Abstract][Full Text] [Related]
3. Comparative effects of desloratadine, fexofenadine, and levocetirizine on nasal adenosine monophosphate challenge in patients with perennial allergic rhinitis.
Lee DK; Gardiner M; Haggart K; Fujihara S; Lipworth BJ
Clin Exp Allergy; 2004 Apr; 34(4):650-3. PubMed ID: 15080821
[TBL] [Abstract][Full Text] [Related]
4. Leukotriene receptor antagonist in the treatment of childhood allergic rhinitis--a randomized placebo-controlled study.
Li AM; Abdullah VJ; Tsen CS; Au CT; Lam HS; So HK; Chan MH; Leung AW; Chan IH; Lam CW; Ng PC
Pediatr Pulmonol; 2009 Nov; 44(11):1085-92. PubMed ID: 19746439
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the combinations of fexofenadine-pseudoephedrine and loratadine-montelukast in the treatment of seasonal allergic rhinitis.
Moinuddin R; deTineo M; Maleckar B; Naclerio RM; Baroody FM
Ann Allergy Asthma Immunol; 2004 Jan; 92(1):73-9. PubMed ID: 14756468
[TBL] [Abstract][Full Text] [Related]
6. Effects of monotherapy with intra-nasal corticosteroid or combined oral histamine and leukotriene receptor antagonists in seasonal allergic rhinitis.
Wilson AM; Orr LC; Sims EJ; Lipworth BJ
Clin Exp Allergy; 2001 Jan; 31(1):61-8. PubMed ID: 11167952
[TBL] [Abstract][Full Text] [Related]
7. Do the leukotriene receptor antagonists work in children with grass pollen-induced allergic rhinitis?
Keskin O; Alyamac E; Tuncer A; Dogan C; Adalioglu G; Sekerel BE
Pediatr Allergy Immunol; 2006 Jun; 17(4):259-68. PubMed ID: 16771779
[TBL] [Abstract][Full Text] [Related]
8. Randomized, double-blind, placebo-controlled study of montelukast for treating perennial allergic rhinitis.
Patel P; Philip G; Yang W; Call R; Horak F; LaForce C; Gilles L; Garrett GC; Dass SB; Knorr BA; Reiss TF
Ann Allergy Asthma Immunol; 2005 Dec; 95(6):551-7. PubMed ID: 16400895
[TBL] [Abstract][Full Text] [Related]
9. A comparison of once daily fexofenadine versus the combination of montelukast plus loratadine on domiciliary nasal peak flow and symptoms in seasonal allergic rhinitis.
Wilson AM; Orr LC; Coutie WJ; Sims EJ; Lipworth BJ
Clin Exp Allergy; 2002 Jan; 32(1):126-32. PubMed ID: 12002729
[TBL] [Abstract][Full Text] [Related]
10. A proof-of-concept study to assess the putative dose response to topical corticosteroid in persistent allergic rhinitis using adenosine monophosphate challenge.
Barnes ML; Menzies D; Nair AR; Hopkinson PJ; Lipworth BJ
Clin Exp Allergy; 2007 May; 37(5):696-703. PubMed ID: 17456217
[TBL] [Abstract][Full Text] [Related]
11. Effects of intranasal corticosteroid on nasal adenosine monophosphate challenge in persistent allergic rhinitis.
Barnes ML; Biallosterski BT; Fujihara S; Gray RD; Fardon TC; Lipworth BJ
Allergy; 2006 Nov; 61(11):1319-25. PubMed ID: 17002709
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of leukotriene antagonists as concomitant therapy in allergic rhinitis.
Cingi C; Gunhan K; Gage-White L; Unlu H
Laryngoscope; 2010 Sep; 120(9):1718-23. PubMed ID: 20717951
[TBL] [Abstract][Full Text] [Related]
13. The effects of an H3 receptor antagonist (PF-03654746) with fexofenadine on reducing allergic rhinitis symptoms.
Stokes JR; Romero FA; Allan RJ; Phillips PG; Hackman F; Misfeldt J; Casale TB
J Allergy Clin Immunol; 2012 Feb; 129(2):409-12, 412.e1-2. PubMed ID: 22196768
[TBL] [Abstract][Full Text] [Related]
14. Comparison of montelukast and pseudoephedrine in the treatment of allergic rhinitis.
Mucha SM; deTineo M; Naclerio RM; Baroody FM
Arch Otolaryngol Head Neck Surg; 2006 Feb; 132(2):164-72. PubMed ID: 16490874
[TBL] [Abstract][Full Text] [Related]
15. Repeated dosing effects of mediator antagonists in inhaled corticosteroid-treated atopic asthmatic patients.
Lee DK; Jackson CM; Haggart K; Lipworth BJ
Chest; 2004 Apr; 125(4):1372-7. PubMed ID: 15078748
[TBL] [Abstract][Full Text] [Related]
16. Randomized controlled trial evaluating the clinical benefit of montelukast for treating spring seasonal allergic rhinitis.
van Adelsberg J; Philip G; LaForce CF; Weinstein SF; Menten J; Malice MP; Reiss TF;
Ann Allergy Asthma Immunol; 2003 Feb; 90(2):214-22. PubMed ID: 12602669
[TBL] [Abstract][Full Text] [Related]
17. Effects of montelukast on quality of life in patients with persistent allergic rhinitis.
Cingi C; Ozlugedik S
Otolaryngol Head Neck Surg; 2010 May; 142(5):654-8. PubMed ID: 20416451
[TBL] [Abstract][Full Text] [Related]
18. Fluticasone nasal spray and the combination of loratadine and montelukast in seasonal allergic rhinitis.
Saengpanich S; deTineo M; Naclerio RM; Baroody FM
Arch Otolaryngol Head Neck Surg; 2003 May; 129(5):557-62. PubMed ID: 12759270
[TBL] [Abstract][Full Text] [Related]
19. Effects of fexofenadine and desloratadine on subjective and objective measures of nasal congestion in seasonal allergic rhinitis.
Wilson AM; Haggart K; Sims EJ; Lipworth BJ
Clin Exp Allergy; 2002 Oct; 32(10):1504-9. PubMed ID: 12372132
[TBL] [Abstract][Full Text] [Related]
20. Targeting adenosine receptors in the treatment of allergic rhinitis: a randomized, double-blind, placebo-controlled study.
Rimmer J; Peake HL; Santos CM; Lean M; Bardin P; Robson R; Haumann B; Loehrer F; Handel ML
Clin Exp Allergy; 2007 Jan; 37(1):8-14. PubMed ID: 17210036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]